THIRTEEN COMPANIES made their pitch to an overflow crowd of potential investors, including venture capitalists such as Mark A. Pritchard, chairman and founder of Allied Minds, a Boston-based firm that invests in products developed through college research.
PROVIDENCE – A bumper crop of Rhode Island-based talent and startup companies were on display at the Life Sciences Technology Showcase on Oct. 12, hosted by the Rhode Island Center for Innovation and Entrepreneurship, Brown University’s Technology Ventures Office, and the Warren Alpert Medical School.
Thirteen companies made their pitch to an overflow crowd of potential investors, including venture capitalists such as Mark A. Pritchard, chairman and founder of Allied Minds, a Boston-based firm that invests in products developed through college research. They included:
Lubris, which has developed an anti-adhesive protein injection to enhance joint protection and function.
Myomics, which has developed small molecule therapeutics to improve muscular function.
Perosphere, which has developed an oral delivery formulation of the anticoagulant heparin.
ProThera BioLogics, which has developed treatments for sepsis, inflammatory and viral diseases.
Tivorsan, which has developed a protein-based therapy to delay or reverse progression of muscular dystrophy.
Ardane Therapeutics, which has developed a peptide drug to treat glaucoma.
Bio-Tree, which has developed a novel micro-vascular geometry morphology informatics for disease diagnostics.
Biointraface, which has developed an anti-microbial coating to reduce infections from orthopedic implants.
MicroTissues Inc., which sells the 3D PetriDish used for research, drug discovery and testing, which was developed as part of the creation of an artificial human ovary.
Mnemosyne Therapeutics, which has developed new treatments for psychiatric disorders such as schizophrenia, targeting subunit selective NMDA receptors in the brain.
NeuPlay, which has developed joint-specific toy controllers as rehabilitation devices for children with cerebral palsy.
CytoSolv, which has developed a biologic drug to speed healing of diabetic ulcers.
Lucidux, which has developed 3D imaging software for minimally invasive surgery.
Potential investors were delighted by the opportunity, according to Terry Norchi, a research analyst from Boston. “Here, everything feels very accessible in Rhode Island, and there’s a lot of talent,” he said. “There are good investors here [at the event], good scientists; everyone is smiling. There’s a lot of opportunity.”
Attention Nonprofit Executives. Join PBN and Adler Pollock & Sheehan for an important Summit on What You Need to Know for 2014. Wednesday, December 11, 8-10:00am at the Crowne Plaza in Warwick. Seating is limited. Register early.
PBN's annual Book of Lists has been an essential resource for the local business community for almost 30 years. The Book of Lists features a wealth of company rankings from a variety of fields and industries, including banking, health care, real estate, law, hospitality, education, not-for-profits, technology and many more.